Skip to Main Content

DexCom, Inc. (NASDAQ: DXCM) Securities Fraud Class Action

View Complaint
COMPANY       DexCom, Inc.
COURT United States District Court for the Southern District of California
CASE NUMBER 24-cv-01485
JUDGE The Hon. Robert Steven Huie
CLASS PERIOD  April 28, 2023 through July 25, 2024
SECURITY TYPE  Securities

Class Background:

Throughout the Class Period, on earnings and shareholder calls, Defendants continually praised their alleged growth, foreseeing record numbers of new patients and outpacing their prior fiscal year’s gross margins, while continually minimizing the risks associated with scaling their customer transition to the G7 platform, as well as those associated with seasonality and the potential impact of the macroeconomic environment on the company’s profitability.

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) DexCom’s communications about growth and anticipated margins were unreasonably optimistic due to its reliance on attracting new customers; (2) DexCom was struggling to keep existing distribution channels successful; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Current Status of Case:

On December 13, 2024, the Court entered an Order Appointing Lead Plaintiff and Lead Counsel.  This action is ongoing.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Complete this form with your transactions in DexCom, Inc. securities between April 28, 2023 and July 25, 2024.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of DexCom, Inc. prior to the Class Period?
Are you a current or former employee of DexCom, Inc.?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email